Skip to Content

Imagin Medical Inc IMEXF

Morningstar Rating
$0.02 +0.02 (1,458.33%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

IMEXF is trading at a 53% premium.
Price
$0.02
Fair Value
$2.69
Uncertainty
Extreme
1-Star Price
$7.16
5-Star Price
$3.62
Economic Moat
Rlxw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IMEXF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.020.04
52-Week Range
$0.000.09
Bid/Ask
$0.01 / $0.06
Market Cap
$202,523.17
Volume/Avg
7,217 / 5,301

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Imagin Medical Inc is a surgical imaging company focused on developing technology to visualize cancer during minimally invasive procedures. Its initial focus is bladder cancer. Imagin's first product, the i/Blue Imaging System, is based on optics and light sensors and employs patented ultrasensitive imaging technology. The company believes the system, currently in the manufacturing stage, will significantly improve surgeon's ability to visualize and remove cancer cells. Run by a Boston-based management team, the company will work to enhance its market potential in the future by expanding its technology to multiple endoscopic procedures, such as laparoscopic and thoracic procedures, accommodating multiple contrast agents and illumination sources.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees

Valuation

Metric
IMEXF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
IMEXF
Quick Ratio
0.00
Current Ratio
0.01
Interest Coverage
−107.14
Quick Ratio
IMEXF

Profitability

Metric
IMEXF
Return on Assets (Normalized)
−246.34%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
IMEXF
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
XjyyrbrrRxhzzb$186.6 Bil
Stryker Corp
SYK
PkdkpslxwGcy$129.7 Bil
Boston Scientific Corp
BSX
CjvpxzmwRyzgtph$114.3 Bil
Medtronic PLC
MDT
LdzglrtrvFqlvzk$102.5 Bil
Edwards Lifesciences Corp
EW
CpmrrfbmwqRwbnxz$52.4 Bil
DexCom Inc
DXCM
WxzgqbjnDxyfb$44.3 Bil
Koninklijke Philips NV ADR
PHG
PfjkdjqplClmnnzt$24.4 Bil
Steris PLC
STE
JjghxxvkDynvcn$22.9 Bil
Zimmer Biomet Holdings Inc
ZBH
QrdjwvlkTvyn$22.7 Bil
Align Technology Inc
ALGN
ZwcsdbrYdyhg$18.4 Bil

Sponsor Center